메뉴 건너뛰기




Volumn 31, Issue 9-10, 2004, Pages 1301-1325

Market valuation of successful versus non-successful R&D efforts in the pharmaceutical industry

Author keywords

Intangibles; Pharmaceutical industry; R D; Valuation

Indexed keywords


EID: 34648849415     PISSN: 0306686X     EISSN: 14685957     Source Type: Journal    
DOI: 10.1111/j.0306-686X.2004.00575.x     Document Type: Article
Times cited : (30)

References (29)
  • 1
    • 0030213196 scopus 로고    scopus 로고
    • Value relevance of nonfinancial information: Thewireless communications industry
    • August-December
    • Amir, E. and B. Lev (1996), 'Value Relevance of Nonfinancial Information: TheWireless Communications Industry', Journal of Accounting & Economics, Vol. 22 (August-December), pp. 3-30.
    • (1996) Journal of Accounting & Economics , vol.22 , pp. 3-30
    • Amir, E.1    Lev, B.2
  • 4
    • 84990378574 scopus 로고    scopus 로고
    • Using non-financial information to predict financial performance: The case of the U.S. Airline industry
    • Behn, B.K. and R.A. Riley Jr. (1999), 'Using Non-financial Information to Predict Financial Performance: The Case of the U.S. Airline Industry', Journal of Accounting, Auditing, and Finance, Vol. 14 (Winter), pp. 29-56.
    • (1999) Journal of Accounting, Auditing, and Finance , vol.14 , Issue.WINTER , pp. 29-56
    • Behn, B.K.1    Riley Jr., R.A.2
  • 8
    • 0003077926 scopus 로고    scopus 로고
    • Science & technology as predictors of stock performance
    • Deng, Z., B. Lev and F. Narin (1999), 'Science & Technology as Predictors of Stock Performance', Financial Analysts Journal, Vol. 55, pp. 20-32.
    • (1999) Financial Analysts Journal , vol.55 , pp. 20-32
    • Deng, Z.1    Lev, B.2    Narin, F.3
  • 10
    • 21844487341 scopus 로고
    • Do important drugs reach the market sooner?
    • Dranove, D. and D. Meltzer (1994), 'Do Important Drugs Reach the Market Sooner?' Rand Journal of Economics, Vol. 25 (Autumn), pp. 402-23.
    • (1994) Rand Journal of Economics , vol.25 , Issue.AUTUMN , pp. 402-423
    • Dranove, D.1    Meltzer, D.2
  • 11
    • 77951518317 scopus 로고    scopus 로고
    • Drug development status in the evaluation of research and development costs
    • The Usefulness of Biotechnology Firms
    • Ely, K., P. Simko and L.G. Thomas (2002), 'The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs', Working Paper (Georgia Institute of Technology).
    • (2002) Working Paper (Georgia Institute of Technology)
    • Ely, K.1    Simko, P.2    Thomas, L.G.3
  • 12
    • 0011314731 scopus 로고
    • Accounting for research and development costs
    • Financial Accounting Standards Board (FASB
    • Financial Accounting Standards Board (FASB) (1974), 'Accounting for Research and Development Costs', Statement of Financial Accounting Standards No. 2.
    • (1974) Statement of Financial Accounting Standards No. 2
  • 13
    • 58149210589 scopus 로고
    • The information content of losses
    • Hayn, C. (1995), 'The Information Content of Losses', Journal of Accounting and Economics, Vol. 20, pp. 125-53.
    • (1995) Journal of Accounting and Economics , vol.20 , pp. 125-153
    • Hayn, C.1
  • 14
    • 84885627663 scopus 로고
    • Intangible capital aspects of advertising and R&D expenditures
    • June
    • Hirschey, M. (1982), 'Intangible Capital Aspects of Advertising and R&D Expenditures', The Journal of Industrial Economics (June), pp. 375-90.
    • (1982) Journal of Industrial Economics , pp. 375-390
    • Hirschey, M.1
  • 15
    • 0001753445 scopus 로고
    • Amortization policy for advertising and research and development expenditures
    • (Spring)
    • - and J.J. Weygandt (1985), 'Amortization Policy for Advertising and Research and Development Expenditures', Journal of Accounting Research (Spring), pp. 326-35.
    • (1985) Journal of Accounting Research , pp. 326-335
    • Weygandt, J.J.1
  • 16
    • 0042253188 scopus 로고    scopus 로고
    • Value relevance of nonfinancial information: The case of patent data
    • -, V.J. Richardson and S. Scholz (2001), 'Value Relevance of Nonfinancial Information: The Case of Patent Data', Review of Quantitative Finance and Accounting, Vol. 17 (November), pp. 223-35.
    • (2001) Review of Quantitative Finance and Accounting , vol.17 , Issue.NOVEMBER , pp. 223-235
    • Richardson, V.J.1    Scholz, S.2
  • 17
    • 0030079993 scopus 로고    scopus 로고
    • The capitalization, amortization, and value-relevance of R&D
    • Lev, B. and T. Sougiannis (1996), 'The Capitalization, Amortization, and Value-relevance of R&D', Journal of Accounting and Economics, Vol. 21, pp. 107-38.
    • (1996) Journal of Accounting and Economics , vol.21 , pp. 107-138
    • Lev, B.1    Sougiannis, T.2
  • 18
    • 84984180909 scopus 로고
    • Earnings, book values, and dividends in equity valuation
    • Ohlson, J.A. (1995), 'Earnings, Book Values, and Dividends in Equity Valuation', Contemporary Accounting Research, Vol. 11 (Spring), pp. 661-87.
    • (1995) Contemporary Accounting Research , vol.11 , Issue.SPRING , pp. 661-687
    • Ohlson, J.A.1
  • 19
    • 6844253629 scopus 로고    scopus 로고
    • (available at) September 8
    • Pharmaceutical Researchers and Manufacturers Association (PhRMA) (1997), 'Industry Profile' (available at http://www.pharma.org/facts/industry/index. html) (September 8).
    • (1997) Industry Profile
  • 20
    • 0344609831 scopus 로고    scopus 로고
    • available at, February 9
    • - (2002), 'Industry Profile' (available at http://www.phrma.org/ publications/profile01/chapter2.phtml) (February 9).
    • (2002) Industry Profile
  • 22
    • 77951616773 scopus 로고    scopus 로고
    • Value relevance of accounting data: An investigation of the economic and accounting contexts in the pharmaceutical industry
    • Shores, D. and R.M. Bowen (2002), 'Value Relevance of Accounting Data: An Investigation of the Economic and Accounting Contexts in the Pharmaceutical Industry', Working Paper (University of Washington).
    • (2002) Working Paper, University of Washington
    • Shores, D.1    Bowen, R.M.2
  • 23
    • 0002111199 scopus 로고
    • The accounting based valuation of corporate R&D
    • Sougiannis, T. (1994), 'The Accounting Based Valuation of Corporate R&D', The Accounting Review, Vol. 69, pp. 44-68.
    • (1994) The Accounting Review , vol.69 , pp. 44-68
    • Sougiannis, T.1
  • 25
    • 0002385715 scopus 로고    scopus 로고
    • Pharmaceuticals: Redesigning R&D
    • Thayer, A.M. (1998), 'Pharmaceuticals: Redesigning R&D', Chemical & Engineering News, Vol. 76 (February), pp. 25-27.
    • (1998) Chemical & Engineering News , vol.76 , Issue.FEBRUARY , pp. 25-27
    • Thayer, A.M.1
  • 26
    • 77951522459 scopus 로고    scopus 로고
    • Biotech and pharmaceuticals
    • Thuermer, K.E. (1998), 'Biotech and Pharmaceuticals', World Trade, Vol. 11 (March), pp. 52-53.
    • (1998) World Trade , vol.11 , Issue.MARCH , pp. 52-53
    • Thuermer, K.E.1
  • 27
    • 77951558481 scopus 로고    scopus 로고
    • The impact of federally funded basic research on industrial innovation: Evidence from the pharmaceutical industry
    • Toole, A.A. (1997), 'The Impact of Federally Funded Basic Research on Industrial Innovation: Evidence from the Pharmaceutical Industry', Working Paper (Laurits R. Christensen Associates).
    • (1997) Working Paper (Laurits R. Christensen Associates)
    • Toole, A.A.1
  • 29
    • 0000095552 scopus 로고
    • A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
    • White, H. (1980), 'A Heteroskedasticity-consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity', Econometrica, Vol. 48, pp. 817-38.
    • (1980) Econometrica , vol.48 , pp. 817-838
    • White, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.